Intervention Protocol

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers

  1. In Sook Friis1,
  2. Matthias Kochanek2,
  3. Ina Monsef1,
  4. Nicole Skoetz1,
  5. Andreas Engert1,
  6. Kathrin Bauer1,*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 5 OCT 2011

DOI: 10.1002/14651858.CD009357


How to Cite

Friis IS, Kochanek M, Monsef I, Skoetz N, Engert A, Bauer K. Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD009357. DOI: 10.1002/14651858.CD009357.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Cologne, Department I of Internal Medicine, Cologne, Germany

*Kathrin Bauer, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. kathrin.bauer@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 5 OCT 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will evaluate the efficacy of intravenous immunoglobulin (IVIG) in the treatment of infections in patients with haematological malignancies with respect to the duration of infections, study mortality, infection-related mortality, adverse events, infection and duration of hospitalisation.